Journal of Cardiovascular Disease Research
Intralesional MMR in WARTS: A Research Article
Dr Chandni S Likhiya, Dr Darshan S Likhiya, Dr Meet P Kachhadiya
JCDR. 2024: 723 -727
Abstract
Warts are benign epidermal tumor caused by human papilloma virus. Immunotherapy appears to enhance virus recognition by immune system, allowing clearance of treated wart, distant warts and helps to prevent infection.0.5 ml intralesional MMR vaccine into a single wart or the largest wart in case of multiple lesions. Intralesional vaccine was given every 02 weeks into the same wart for 03 doses. Intralesional immunotherapy with MMR vaccine was found to be a simple, effective, and safe treatment for warts. This study proved to be cost effective as patients can be treated with just 03 doses of MMR vaccine given at the interval of two weeks.
» PDF